Experience

On Demand Pharmaceuticals, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Scientist

  • Oct 2020 - Present

  Develop continuous manufacturing processes for generic small molecule drug substances for a pharmaceutical start up. I develop synthesis, purification, and isolation protocols in batch, translate these methods into continuous flow chemistry methods, and develop design space and process parameters for each process. Develop continuous manufacturing processes for generic small molecule drug substances for a pharmaceutical start up. I develop synthesis, purification, and isolation protocols in batch, translate these methods into continuous flow chemistry methods, and develop design space and process parameters for each process.



FDA

• Canada
• Advertising Services
• 1 - 100 Employee

• Chemist

  • Jun 2018 - Oct 2020

  Provides expertise as a chemist for veterinary drug product and drug substance review. I evaluate changes to chemistry, manufacturing and methodology changes according to ICH/VICH, FDA, and USP guidelines to assess their impact on drug products and substances. Provides expertise as a chemist for veterinary drug product and drug substance review. I evaluate changes to chemistry, manufacturing and methodology changes according to ICH/VICH, FDA, and USP guidelines to assess their impact on drug products and substances.



University of South Florida

• United States
• Higher Education
• 700 & Above Employee

• Graduate Research and Teaching Assistant

  • Aug 2013 - May 2018

  Small molecule natural products chemist, utilizing analytical chromatographic and spectroscopic techniques to identify and isolate new, bioactive compounds from mangrove endophytes and Antarctic sponges. Managed a high-throughput cultivation and screening of ~10,000 epigenetically tailored, Floridian mangrove endophyte extracts against bacterial and parasitic disease targets. Developed Mass Spectrometry (MS) based dereplication strategies for fungal endophyte extracts, including a Tandem MS- and chemical structure-based metabolite and toxin database, and a Liquid Chromatography/MS selective extraction of toxins from crude extracts. Isolated and elucidated the structures of a series of new, fully N-methylated small molecule peptides from Antarctic sponges. Isolated and elucidated the structures of new bioactive benzoxazepines from an epigenetically tailored endophyte fungus.



John Carroll University

• United States
• Higher Education
• 700 & Above Employee

• Teaching Assistant

  • Sep 2010 - May 2013



Sherwin-Williams

• United States
• Chemical Manufacturing
• 700 & Above Employee

• Summer Intern

  • May 2012 - Aug 2012



Texas A&M University

• United States
• Higher Education
• 700 & Above Employee

• Summer Intern

  • May 2011 - Aug 2011

  Synthesized new bi- and tri-dentate tungsten metal-ligand complexes. Characterization of these complexes, and molybdenum analogues, were characterized using UV-Vis and NMR spectroscopy, and X-Ray crystallography. Synthesized new bi- and tri-dentate tungsten metal-ligand complexes. Characterization of these complexes, and molybdenum analogues, were characterized using UV-Vis and NMR spectroscopy, and X-Ray crystallography.